News
The truth is, a recall notice is rarely the end of the story. Instead, it marks the beginning of a longer, more personal ...
The Hospital Authority says it is proactively following up with medical device supplier Abbott Laboratories about the product ...
Product recalls are a major headache for pharma, but device manufacturers can feel the pain, too. In the U.S., the FDA's 510(k) process for approval is under intense scrutiny 1, with critics ...
This week, many products were recalled from shops like Priceline and Chemist Warehouse, with Toyota also recalling one of ...
IndustryWeek editors look into that story, plus an electric boat makes history, what's up with product recalls, Morgan Li ...
A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool.
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of one ...
14d
Zacks.com on MSNIs it Worth Retaining ResMed Stock in Your Portfolio Now?ResMed Inc.’s RMD growth in the third quarter of fiscal 2025 can be attributed to the robust performance of its Mask business ...
Kirkland & Ellis has hires a 13-partner team from King & Spalding to boost its mass torts and product liabilities capability ...
Developed by Binaural Technologies, The Brain Song Uses a NASA-Inspired Gamma Wave Formula to Stimulate BDNF and Enhance ...
6d
Zacks Investment Research on MSNBD Stock Might See Short-term Decline After Warning on Tamponade TubesBecton, Dickinson and Company BDX, popularly known as BD, along with its subsidiary C.R. Bard Urology and Critical Care, ...
1d
Livewire Markets on MSN9 ASX growth stocks vs their global twins: Which is the better buy?The ASX has a rich vein of quality growth companies, but in some instances, international stocks have better prospects and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results